Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 749 Jan 1 – Oct 24, 2026
- Disclosed funding
- $25.9B 609 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| AB ARTAN BioCompany profile Develops mutation-specific codon suppression technologies to address genetic diseases and aging-related conditions Develops mutation-specific codon suppression technologies to address genetic diseases and aging-related conditions | $200K | Seed | Healthtech, Biotech | United States | Investors | |
| FH Flok HealthCompany profile AI-operated digital physiotherapy clinic delivering autonomous musculoskeletal care pathways via mobile app AI-operated digital physiotherapy clinic delivering autonomous musculoskeletal care pathways via mobile app | $12.5M | Series A | Healthtech | United Kingdom | Investors | |
| IH Ilant HealthCompany profile Delivers AI-enabled, value-based obesity and cardiometabolic care to employers and health plans Delivers AI-enabled, value-based obesity and cardiometabolic care to employers and health plans | $15M | Series A | Healthtech | United States | Investors | |
| RH Radley HealthCompany profile Provides peer support services for adults with serious mental illness across Ohio Provides peer support services for adults with serious mental illness across Ohio | $3M | Seed | Healthtech | United States | Investors | |
| A Provides home care management software for agencies | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors | |
| AN Advanced NanoTherapiesCompany profile Advanced NanoTherapies develops nanoparticle-coated balloons that deliver two drugs locally during vascular procedures, starting with its investigational SirPlux Duo device. Advanced NanoTherapies develops nanoparticle-coated balloons that deliver two drugs locally during vascular procedures, starting with its investigational SirPlux Duo device. | >$31M | Series B | Healthtech | United States | Investors | |
| IB IMU BiosciencesCompany profile Profiles human immune systems using multi-omic analysis and machine learning for disease research. Profiles human immune systems using multi-omic analysis and machine learning for disease research. | $53M | Series A | Healthtech, Biotech | United Kingdom | Investors | |
| TB Develops novel therapeutics for glaucoma and retinal diseases | $17M | Series A | Healthtech, Biotech | United States | Investors | |
| C ContralineCompany profile Develops hormonal and non-hormonal male contraceptives for men and couples globally Develops hormonal and non-hormonal male contraceptives for men and couples globally | $92.5M | Series B | Healthtech, Biotech | United States | Investors | |
| SM Subtle MedicalCompany profile Develops AI-powered medical imaging software to improve workflow efficiency and image quality Develops AI-powered medical imaging software to improve workflow efficiency and image quality | $33M | Growth | Healthtech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.